SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Attention centers on SELLASs anticipated Phase 3 REGAL topline results for its GPS leukemia treatment, a binary catalyst that has traders weighing hopes for a positive readout against concerns about trial failure. The debate is intensified by sharp price swings, with bullish claims of short pressure and manipulation contested by skeptics who see the outcome as uncertain.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Reported preliminary takeover discussions involving Silver Lake and Saudi Arabias PIF are fueling attention, though traders debate whether the valuation discussed is too low and whether a deal will happen. The speculation comes alongside Unitys strong Q3 results, first GAAP-profitable quarter, and rapid Vector ad growth, which some traders argue support the companys standalone value.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians persistent share-price weakness and choppy trading dominate discussion, with traders attributing pressure to short-selling or options activityclaims that remain speculative. Bulls point to Q3 progress, R2 recognition and the upcoming Autonomy & AI Day, while skeptics focus on cash burn, profitability and management execution.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit is in focus ahead of the FDAs PDUFA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer. Traders are split: bulls point to strong progression-free-survival results, improving survival trends and AstraZenecas backing, while bears emphasize that the trial missed statistical significance for overall survival and the FDA indicated that evidence was needed.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

A sharp, high-volume move has revived speculation about a Big Pharma partnership or buyout for Vikings obesity-drug pipeline, particularly VK2735, alongside attention to its ObesityWeek presentations. Traders disagree on whether the activity signals genuine strategic interest or is another rumor-fueled trading surge; no deal is confirmed.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs abrupt departure has put Nvidias leadership succession in focus, with reports that the board approached Arm CEO Rene Haas and speculation among traders that Huang could return. The community is split between buyers who see Nvidias AI-chip business and upcoming results as resilient and skeptics concerned about succession uncertainty, governance scrutiny, and possible fallout from export investigations.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is under pressure after its outlook raised concerns about delayed third-party data-center capacity and revenue timing, with analyst downgrades and weakness across AI infrastructure stocks adding to the selloff. Traders are divided between expecting further losses and viewing the decline as an overreaction and a buying opportunity.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

A quarterly earnings beat and higher full-year outlook, supported by strong demand for the Wegovy pill, are fueling renewed interest in Novo Nordisk. Bulls see evidence of a recovery, while skeptics point to diabetes weakness, pricing pressure and competition from Eli Lilly as reasons to question whether the turnaround will last.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is drawing attention over the squeeze from elevated jet-fuel costs, linked by traders to oil-market disruption and the Iran conflict, with recent earnings discussion highlighting that strong revenue has not translated into profits and the outlook has weakened. Bears worry about prolonged fuel pressure and AALs debt, while bulls see room for recovery if oil prices ease and travel demand remains firm.

HawKeye 360, Inc. engages in the provision of defense technology. It offers spectrum monitoring, maritime intelligence, air defence radar monitoring, GNSS interference detection, and communications mapping. Its costumers include a wide range of commercial, government and international entities. The company was founded by Charles T. Clancy, Robert G. McGwier, Chris DeMay and John Serafini in 2015 and is headquartered in Herndon, VA.

HawkEye 360 Inc.

HAWK is drawing attention after reporting record third-quarter revenue and raising its full-year outlook, with traders also highlighting the earnings-call discussion of international growth, cash reserves and lower-cost satellites. The reaction is broadly bullish amid a sharp, high-volume rise, though claims of institutional accumulation remain speculation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 25.1% to $3.79 during Monday's after-market session. The company's market cap stands at $1.8 million.
China Pharma Holding (AMEX:CPHI)read more...

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular session. The market value of their outstanding shares is at $7.8 million.
Shuttle Pharmaceuticals (NASDAQ:SHPH) sharesread more...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

NextCure (NASDAQ:NXTC) shares rose 305.5% to $8.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.8 million.
Shuttle Pharmaceuticals (NASDAQ:SHPH) stock movedread more...

Gainers

Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-market session. The company's market cap stands at $1.7 million.
Medicus Pharma (NASDAQ:MDCX) stock rose 7.46% toread more...

SHPH, ILLR, IVF: Why These Stocks Posted Double-Digit Gains After-Hours Today 

Equity

AI infrastructure plan, SpaceX exposure, and Nasdaq compliance update boosted investor sentiment. 


12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers

Shuttle Pharmaceuticals (NASDAQ:SHPH) shares moved upwards by 66.9% to $6.31 during Thursday's after-market session. The company's market cap stands at $2.1 million.
INVO Fertility (NASDAQ:IVF) stockread more...

Bitcoin Rises Toward $80,000 After Oil Drops On Iran Peace Signals – Triggers $200 Million Short Squeeze

Cryptocurrency

Bitcoin’s price rose to an intraday high of nearly $80,000 as oil prices eased after reports of a potential Iran-U.S. peace deal.


Why Is SHPH Stock Soaring Today? Dogecoin Mining Pivot Sparks Rally 

Shuttle Pharmaceutical Holdings signed a definitive merger agreement to acquire United Dogecoin and become a Dogecoin miner.

5 Biotech Stocks with Highly Anticipated Pending Results

Others

Biotech M&A is heating up, making small-cap firms with breakthrough assets top acquisition targets and potential big winners for investors.

Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations

George Scorsis takes helm as Chairman as Ropidoxuridine trial nears 50% enrollment and patent advances boost pipeline.

Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and is headquartered in Gaithersburg, MD.

Shuttle Pharmaceuticals Holdings Inc

Bearish Sentiment

<ul class="summary-bullets"><li>Shuttle Pharmaceuticals’ subsidiary, United Dogecoin, announced plans to expand data centers and power assets in Idaho and Alberta.&nbsp;</li><li>Triller Group soared after announcing a deal for indirect exposure to SpaceX.</li><li>INVO Fertility took full ownership of its Alabama clinic and resolved its Nasdaq compliance matter.&nbsp;</li></ul>Shuttle Pharmaceuticals Holdings (SHPH), Triller Group (ILLR), and INVO Fertility (IVF),&nbsp;all small-cap stocks, posted double-digit gains in after-hours trading on Thursday as&nbsp;company-specific developments prompted strong buying interest.Each update centered on initiatives aimed at strengthening long-term growth, improving financial positioning, or expanding operations.<h2 class="st-heading-2">SHPH Broadens Infrastructure Plans</h2>Shuttle Pharmaceuticals drew attention after its recently acquired subsidiary, United Dogecoin Inc., outlined plans to expand into data center infrastructure and power generation assets in Idaho and Alberta, Canada.The initiative is designed to support cryptocurrency mining while also creating capacity for commercial AI computing.The announcement signals a shift in Shuttle Pharma's long-term strategy. While the company continues to develop its Molecule.ai platform to accelerate early-stage drug discovery, management is also pursuing investments in physical computing infrastructure.&nbsp;<a href="https://stocktwits.com/symbol/SHPH">Shuttle Pharmaceuticals' stock</a> traded over 44% higher overnight. On Stocktwits, retail sentiment around the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day.&nbsp;<h2 class="st-heading-2">ILLR Targets SpaceX Exposure</h2>Triller Group recorded one of the market's biggest moves on Thursday after announcing a&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/illr-stock-surged-more-than-400-today-why-is-this-tik-tok-rival-buying-space-x-shares/cZ1GV1nR7Xf">transaction</a> that would give it indirect economic exposure to SpaceX (SPCX). The stock surged 296% during the regular session before adding more than 30% in after-hours trading, as investors welcomed the company's shift toward a high-value balance sheet strategy.The stock jumped after Triller announced a deal to acquire an investment vehicle with interests in millions of SpaceX Class A shares. The news came just days after its 1-for-10 reverse stock split, shifting investor attention from the share restructuring to the company's new investment strategy.&nbsp;<a href="https://stocktwits.com/symbol/ILLR">Triller Group</a> stock traded over 35% higher overnight. Retail sentiment around the stock jumped to ‘extremely bullish’ from ‘neutral’ territory the previous day.&nbsp;<h2 class="st-heading-2">Dual Announcements Lift Investor Confidence On IVF&nbsp;</h2>INVO Fertility stock climbed after hours as investors responded positively to the reproductive healthcare company's completion of the purchase of its remaining joint-venture interest in an Alabama fertility clinic and to confirmation that a prior Nasdaq compliance matter had been resolved.The company's latest filings showed it now owns 100% of its Birmingham, Alabama, fertility clinic following the acquisition of its partner's remaining stake. Around the same time, Nasdaq informed INVO that its filing-related compliance issue had been closed following the company's submission of its first-quarter 2026 financial statements.<a href="https://stocktwits.com/symbol/IVF">INVO Fertility stock</a> traded over 50% higher overnight. Retail sentiment around the stock improved to ‘bullish’ from ‘neutral’ territory the previous day.&nbsp;So far this year, while SHPH and IVF stocks cratered 79% and 67%, respectively, ILLR stock has surged 853%.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/googl-waymo-targets-germany-in-next-phase-of-robotaxi-rollout/cZ1Gt3KR7XV">Alphabet’s Waymo Targets Germany In Next Phase of Robotaxi Rollout</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

AI data centers are seen on show at the Mobile World Congress 2026 (MWC) at the Fira de Barcelona.

Shuttle Pharmaceuticals Holdings (SHPH), Triller Group (ILLR), and INVO Fertility (IVF),&nbsp;all small-cap stocks, posted double-digit gains in after-hours trading on Thursday as&nbsp;company-specific developments prompted strong buying interest.

Triller Group Inc.

INVO Fertility, Inc. Common Stock

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$4.53
Prev Close	$4.76
Open	$4.64
Dividend Yield	0.00%
50-Day Moving Average	$4.47
Beta	0.29
Avg. Volume	41,389.91
PE Ratio	-0.15

52-Week High	$44.40
52-Week Low	$2.58
Market Capitalization	$22.68M
EPS (Annual)	-$71.56
Price to Book	0.25
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

SHPH Fundamentals